Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial).
Ashish AwasthiHarshita KatiyarSumit RungtaAmar DeepVinod Kumarnull ShalimarAjay KumarPrachi TiwariAmit GoelPublished in: PloS one (2023)
Registered with Clinical Trial Registry of India (http://ctri.nic.in) Registration No. CTRI/2022/03/041368 [Registered on: 24/03/2022]-Trial Registered Prospectively.